Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Biological Sciences

10-1-2010

HRAS1 and LASS1 with APOE are associated with human
longevity and healthy aging
S. Michal Jazwinski
Tulane University School of Medicine

Sangkyu Kim
Tulane University School of Medicine

Jianliang Dai
Tulane University School of Medicine

Li Li
LSU Health Sciences Center - New Orleans

Xiuhua Bi
Tulane University School of Medicine

See next page for additional authors

Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs

Recommended Citation
Jazwinski, S., Kim, S., Dai, J., Li, L., Bi, X., Jiang, J., Arnold, J., Batzer, M., Walker, J., Welsh, D., Lefante, C.,
Volaufova, J., Myers, L., Su, L., Hausman, D., Miceli, M., Ravussin, E., Poon, L., Cherry, K., & Welsch, M.
(2010). HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell,
9 (5), 698-708. https://doi.org/10.1111/j.1474-9726.2010.00600.x

This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

Authors
S. Michal Jazwinski, Sangkyu Kim, Jianliang Dai, Li Li, Xiuhua Bi, James C. Jiang, Jonathan Arnold, Mark
A. Batzer, Jerilyn A. Walker, David A. Welsh, Christina M. Lefante, Julia Volaufova, Leann Myers, L. Joseph
Su, Dorothy B. Hausman, Michael V. Miceli, Eric Ravussin, Leonard W. Poon, Katie E. Cherry, and Michael
A. Welsch

This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/biosci_pubs/144

Aging Cell (2010) 9, pp698–708

Doi: 10.1111/j.1474-9726.2010.00600.x

HRAS1 and LASS1 with APOE are associated with
human longevity and healthy aging
S. Michal Jazwinski,1 Sangkyu Kim,1,* Jianliang
Dai,1,2,* Li Li,3 Xiuhua Bi,1 James C. Jiang,1 Jonathan
Arnold,2 Mark A. Batzer,4 Jerilyn A. Walker,4 David
A. Welsh,5 Christina M. Lefante,6 Julia Volaufova,6
Leann Myers,7 L. Joseph Su,6,† Dorothy B.
Hausman,8 Michael V. Miceli,1 Eric Ravussin,9
Leonard W. Poon,10 Katie E. Cherry11 and Michael
A. Welsch12 for the Georgia Centenarian Study and
the Louisiana Healthy Aging Study
1
Tulane Center for Aging and Department of Medicine, Tulane
University Health Sciences Center, New Orleans, LA 70112, USA
2
Genetics Department, University of Georgia, Athens, GA 30602,
USA
3
Neuroscience Center, Louisiana State University Health Sciences
Center, New Orleans, LA 70112, USA
4
Department of Biological Sciences, Louisiana State University,
Baton Rouge, LA 70803, USA
5
Department of Medicine, Louisiana State University Health
Sciences Center, New Orleans, LA 70112, USA
6
School of Public Health, Louisiana State University Health
Sciences Center, New Orleans, LA 70112, USA
7
Department of Biostatistics, School of Public Health and Tropical
Medicine, Tulane University Health Sciences Center, New Orleans,
LA 70112, USA
8
Department of Foods and Nutrition, University of Georgia,
Athens, GA 30602, USA
9
Pennington Biomedical Research Center, Baton Rouge, LA
70808, USA
10
Institute of Gerontology, University of Georgia, Athens, GA
30602, USA
11
Department of Psychology, Louisiana State University, Baton
Rouge, LA 70803, USA
12
Department of Kinesiology, Louisiana State University, Baton
Rouge, LA 70803, USA

Aging Cell

Summary
The search for longevity-determining genes in human has
largely neglected the operation of genetic interactions.
We have identified a novel combination of common
variants of three genes that has a marked association
with human lifespan and healthy aging. Subjects were
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recruited and stratified according to their genetically
inferred ethnic affiliation to account for population structure. Haplotype analysis was performed in three candidate genes, and the haplotype combinations were tested
for association with exceptional longevity. An HRAS1
haplotype enhanced the effect of an APOE haplotype on
exceptional survival, and a LASS1 haplotype further augmented its magnitude. These results were replicated in a
second population. A profile of healthy aging was developed using a deficit accumulation index, which showed
that this combination of gene variants is associated with
healthy aging. The variation in LASS1 is functional, causing enhanced expression of the gene, and it contributes
to healthy aging and greater survival in the tenth decade
of life. Thus, rare gene variants need not be invoked to
explain complex traits such as aging; instead rare congruence of common gene variants readily fulfills this role.
The interaction between the three genes described here
suggests new models for cellular and molecular mechanisms underlying exceptional survival and healthy aging
that involve lipotoxicity.
Key words: haplotypes; healthy aging profile; lipotoxicity; longevity genes; population stratification.

Introduction
Exceptional longevity has genetic and environmental components, but in humans they have often been difficult to identify
(Christensen et al., 2006). Most of the research on the genetics of human aging has focused on the genetic risk factors
associated with age-related diseases and disorders, with APOE
being one prime candidate (Christensen et al., 2006). This is
not surprising given the impact of variation in this gene on
cardiovascular and neuropathological aspects of aging (Strittmatter et al., 1993; Schächter et al., 1994; Song et al., 2004;
Christensen et al., 2006). Studies in model systems have also
recently guided the search for genetic determinants of human
longevity, pointing to several pathways and processes contributing to enhanced lifespan (Jazwinski, 1996; Finch & Ruvkun,
2001; Kenyon, 2005). However, this approach has largely been
limited to components of the insulin ⁄ IGF-1 pathway (Hong
et al., 2008; Suh et al., 2008; Willcox et al., 2008). We
decided to expand on this approach by examining the Ras and
ceramide signaling pathways. The involvement of Ras signaling
in lifespan determination has been adduced in studies in yeast
(Chen et al., 1990; Sun et al., 1994) and in mice (Migliaccio
et al., 1999), while the role of ceramide signaling emerges
from research in yeast (D’mello et al., 1994; Jazwinski & Conzelmann, 2002; Guillas et al., 2003) and in Caenorhabditis
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elegans (Tedesco et al., 2008; Mehta et al., 2009; Menuz
et al., 2009).
The APOE e4 allele is a risk factor for early mortality, while
the alleles e2 and e3 are enriched in exceptionally old individuals
in some studies (Christensen et al., 2006). Apolipoprotein E
(APOE) is important in chylomicron and very low density
lipoprotein (VLDL) metabolism (Mahley & Rall, 2000). Thus, it is
one of the factors responsible for maintenance of circulating
lipid homeostasis. This balance can break down with age, and it
is clearly disrupted in some individuals resulting in an increase in
the risk for cardiovascular disease and other disorders (Mahley &
Rall, 2000). The rise in circulating cholesterol and triglycerides
results in vascular damage and can be a cause of lipotoxicity, a
potential trigger of insulin resistance and diabetes (Kusminski
et al., 2009). This lipotoxicity may trigger responses that are
mediated by HRAS1, a small G-protein involved in signal transduction (Ramos, 1999). Furthermore, some of the pathways that
are induced are modulated by ceramide, a product of the ceramide synthase LASS1 (Jazwinski & Conzelmann, 2002; Ogretmen & Hannun, 2004). Ceramide synthase responds to growth
and to stress signals via Tor complex TORC2 and calcineurin,
respectively (Dickson, 2008). Lipotoxicity stimulates ceramide
synthesis (Kusminski et al., 2009), and the resulting ceramide
can signal apoptosis, resulting in the removal of damaged cells
(Koybasi et al., 2004). It can also facilitate the transfer of cholesterol from cells to high density lipoprotein (HDL) (Witting et al.,
2003). Therefore, we postulate that the HRAS1 and LASS1
genes interact genetically with the APOE gene to reduce agerelated increase in lipotoxic events, and that a combination of
variants or haplotypes in these three genes is associated with
exceptional survival.

Results
Gene combination associated with exceptional
longevity
We have initiated a genetic analysis of exceptional longevity in
the Georgia and Louisiana populations. Our attention in this
study was exclusively directed to APOE, HRAS1, and LASS1 in a
candidate gene approach. As noted earlier, variants of APOE are
associated with longevity. This pattern is also found in the Georgia and Louisiana populations, for centenarians and nonagenarians respectively (Table S1). Both the Georgia and Louisiana
populations are admixed with the two major strata being of
European and African origin. To address this problem, we stratified each population by ethnic affiliation using an identical-bydescent (IBD) genetic system (Fig. 1). We placed the subjects in
each population into two major groups of African and European
origin. Together, these two groups constituted 81% and 83%
of subjects of 20–59 years old and 72% and 77% of centenarians and nonagenarians in the Georgia and Louisiana samples,
respectively. The ability to stratify is markedly enhanced by the
Alu system used here, which can trace genealogy within the primate lineage. The mean correct prediction rates with the 100

(A)

All others

European

(B)

European

African

All others

African

Fig. 1 Stratification of the populations by ethnic affiliation. Alu genotypes
and Structure analysis were employed to assign subjects to two major strata,
European and African, in the Georgia (A) and Louisiana (B) populations. The
Structure analysis was carried out in two batches for Louisiana consisting of
434 and 435 samples to speed computation, the latter of which is shown,
while all 650 samples from Georgia were analyzed in one batch. Dots: red
(Georgia or Louisiana samples), green (African control samples), purple
(European control samples), light blue (Asian control samples), orange (Indian
control samples). Indian refers to the Indian subcontinent. Not all samples are
evident owing to superposition of dots.

Alu used here are 95–99% (Bamshad et al., 2003). After stratification the association of APOE with longevity persisted
(Table S2). However, no such association was detected for
HRAS1 or LASS1 here (Table S3).
To test the hypothesis that the genetic interaction postulated
above is associated with longevity, we genotyped the Georgia
sample at the three relevant genomic regions. None of the 15
SNP examined showed significance for departure from Hardy–
Weinberg proportions in either the African or European-origin
populations in Georgia. (The same was found separately for the
Louisiana population.) We searched for combinations of haplotypes in the three genes (15 SNP) in the Georgia population
present at  0.01 or greater frequency, using expectation maximization. We then tested them for association with exceptional
longevity (Table S4). Such associations were detected in the subpopulation of European origin in Georgia, stratified with an
assignment probability of 0.9 (Table 1), but not in the subpopulation of African origin. They involve the e3 containing APOE
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Table 1 Association of haplotypes with exceptional longevity and healthy aging

Population

Haplotype

Georgia

APOEÆHRAS1ÆLASS1 (CCT)

Georgia

APOEÆHRAS1ÆLASS1 (CGT)

Louisiana

APOEÆHRAS1ÆLASS1 (CCT)

Louisiana

APOEÆHRAS1ÆLASS1 (CGT)

Georgia

APOEÆHRAS1ÆLASS1 (CCT)

Georgia

APOEÆHRAS1ÆLASS1 (CGT)

Louisiana

APOEÆHRAS1ÆLASS1 (CCT)

Louisiana

APOEÆHRAS1ÆLASS1 (CGT)

Louisiana

APOEÆHRAS1ÆLASS1 (CCT)

Louisiana

APOEÆHRAS1ÆLASS1 (CGT)

Case (N; frequency)
Control (N; frequency)

OR (CI)

‡ 98 years old (147; 0.073)
20–59 years old (188; 0.010)
‡ 98 years old (147; 0.191)
20–59 years old (188; 0.084)
‡ 90 years old (204; 0.105)
20–59 years old (251; 0.039)
‡ 90 years old (204; 0.175)
20–59 years old (251; 0.067)
‡ 98 -year-old female (128; 0.099)
20–59 -year-old female (115; 0.009)
‡ 98 -year-old male (19; 0.251)
20–59 -year-old male (73; 0.026)
‡ 90- year-old female (125; 0.092)
20–59- year-old female (163; 0.032)
‡ 90 -year-old male (79; 0.279)
20–59- year-old male (88; 0.074)
‡ 90 -year-old healthy (68; 0.023)
‡ 90 -year-old unhealthy (68; 0.076)
‡ 90 -year-old healthy (68; 0.295)
‡ 90- year-old unhealthy (68; 0.026)

Exact P (adjusted P)

7.68 (2.55–23.10)

4.1 · 10)5 (2.88 · 10)4)

2.56 (1.61–4.08)

7.8 · 10)5 (4.66 · 10)4)

2.93 (1.68–5.09)

9.5 · 10)5 (5.68 · 10)4)

2.97 (1.92–4.58)

6.91 · 10)7 (5 · 10)6)

12.52 (2.93–53.57)

1 · 10)5 (2 · 10)5)

12.40 (3.55–43.29)

9 · 10)6 (9 · 10)6)

3.12 (1.47–6.63)

1.97 · 10)3 (3.93 · 10)3)

4.86 (2.50–9.45)

1 · 10)6 (2 · 10)6)

0.29 (0.08–1.04)

*5.11 · 10)2 (5.11 · 10)2)

15.48 (5.08–47.15)

1.06 · 10)9 (2.11 · 10)9)

European subpopulations (0.9 assignment probability) were examined. The haplotypes are ATTTC and CGCGCGT for APOE and HRAS1, respectively. Healthy
and unhealthy were classified as described in Experimental procedures.
OR, odds ratio; CI, 95% confidence interval.
*Not significant.

haplotype (ATTTC) and the HRAS1 (CGCGCGT) haplotype in
combination with the LASS1 (CCT) or (CGT) haplotypes, in
which the SNP are listed starting with the furthest upstream SNP
for each gene. The odds ratios (OR) of 7.68 and 2.56 were
obtained for the APOE, HRAS1, and LASS1 (CCT) or (CGT) haplotype combinations, respectively. The stratification of the population at the 0.9 assignment probability level was sufficient for
this analysis, because no significant differences were observed
in the frequencies of the ethnic affiliation markers between the
control and centenarian groups in the European subpopulation.
To determine whether these associations are present in the
Louisiana population, we carried out the same analyses independently. The results obtained in the Georgia sample replicated in
the Louisiana sample (Table 1). The same haplotype combinations were associated with exceptional longevity in the subpopulation of European origin in Louisiana, stratified with an
assignment probability of 0.9, and no significant association was
found in the African-origin subpopulation. The OR were 2.93
and 2.97 for the APOE, HRAS1, and LASS1 (CCT) or (CGT) haplotype combinations, respectively. The lower OR of the LASS1
(CCT)-containing haplotype combination in the Louisiana population is likely due to the greater demographic selection for centenarians than for nonagenarians in the Georgia and Louisiana
samples, respectively, but this does not appear to apply to the
LASS1 (CGT).
The lack of an association with longevity in the African-American subpopulation from both Georgia and Louisiana could be
attributed to the relatively lower numbers of subjects from this
group. However, it is likely that this may be an intrinsic differ-

Table 2 Haplotype frequencies in the general population
Haplotype
European
Georgia (N = 220)
Louisiana (N = 293)
African
Georgia (N = 145)
Louisiana (N = 52)

APOE

HRAS1

LASS1 (CCT)

LASS1 (CGT)

0.237
0.237

0.634
0.664

0.289
0.253

0.504
0.561

0.041
0.08

0.633
0.60

0.200
0.15

0.333
0.28

A Structure assignment probability of 0.8 was used for this analysis to
provide a conservative evaluation of any differences. The 20- to 59 -yearold age groups were used here, as representative of the general
population. APOE (ATTTC) and HRAS1 (CGCGCGT) haplotypes are shown.

ence in the subpopulation. Analysis of the frequency of the haplotypes in the individual genes supports the notion that there is
an intrinsic difference between the European and African
subpopulations in both Georgia and Louisiana (Table 2). The
major difference is in the APOE haplotype frequency, with a
smaller difference in LASS1. The European populations in Georgia and Louisiana also differ, as an examination of the haplotype
blocks in the three genes suggests (Fig. S1).

Haplotype frequencies differ with age
To ascertain the potential role of the three-gene interaction in
promoting exceptional survival, we examined the differences in
various age groups in the frequency of the two haplotype combinations identified above in the European subpopulation. The
results are shown for the combinations containing the LASS1
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(A)

(B)

Consistent with the increase in haplotype frequencies with
age, the APOE haplotype is associated with exceptional survival
in the European-origin subpopulations from both Georgia and
Louisiana, with OR of 1.53 (CI = 1.08–2.17; Exact P = 2.12 ·
10)2; adjusted P = 2.12 · 10)2) and 1.37 (CI = 1.02–1.83;
Exact P = 4.37 · 10)2; adjusted P = 4.37 · 10)2) respectively.
The APOEÆHRAS1 haplotype combination is also associated with
longevity in both of these subpopulations, with OR of 2.83
(CI = 1.88–4.26; Exact P = 5.68 · 10)7; adjusted P = 1.14 ·
10)6) and 1.89 (CI = 1.35–2.65; Exact P = 2.27 · 10)4;
adjusted P = 4.54 · 10)4) respectively. The greater OR for
the two-gene combination supports the epistatic effect of
HRAS1. None of the other haplotypes in the individual genes
or their combinations were associated with longevity
(Table S5).

Haplotype combinations in women and men

Fig. 2 Haplotype frequencies in different age groups. The frequencies for
each haplotype or haplotype combination determined for the European
subpopulation (0.9 assignment probability) were normalized to the
frequencies in the < 60 year-old-age group from Georgia or Louisiana,
respectively, to facilitate comparison. Error bars denote the SD (100
bootstraps). The age groups labeled ‘90’ and ‘100’ are the nonagenarians and
centenarians in Georgia and Louisiana, respectively. For clarity, only the
haplotypes or haplotype combinations that differ significantly on frequency
between age groups are shown: APOE (ATTTC), HRAS1 (CGCGCGT), and
LASS1 (CCT) in A and APOE (ATTTC), HRAS1 (CGCGCGT), and LASS1 (CGT)
in B. Note the difference in scale of the ordinates in A and B. The APOE and
APOEÆHRAS1 frequencies are identical in the two panels.

(CCT) and (CGT) haplotypes in Fig. 2A,B, respectively. The
monotonic increase in the frequencies of the haplotype combinations of APOEÆHRAS1ÆLASS1 with age indicates a positive
association with longevity, although a plateau appears for the
combination containing the LASS1 (CGT) haplotype for the oldest age group. These positive associations with longevity indicate that these are longevity haplotypes.
We next determined the frequencies of the APOE (ATTTC)
haplotype and its combination with HRAS1 (CGCGCGT) from
the three-gene haplotype combination in the various age
groups. Figure 2 shows that in both cases there is a monotonic
increase with age. None of the other haplotypes in the individual
genes or haplotype combinations changed in frequency with
age. The patterns seen indicate that HRAS1 has a synergistic
(epistatic) effect with APOE, and this effect is further enhanced
by either of the two LASS1 haplotypes (Fig. 2 and Table 1).

The plateau in the frequency of the three-gene haplotype combination containing LASS1 (CGT) in centenarians was puzzling.
One possibility is that this reflects the lack of a role for this haplotype in survival at that late age. However, there is an alternate
explanation. With advanced age, the ratio of females to males
increases. Thus, the plateau we see could be the result of gender
bias in the oldest age groups. We therefore examined the haplotype association in the Georgia sample for females and males
separately, in the European subpopulation. The results suggest
that such a bias indeed exists (Table 1). The association with
exceptional survival in female centenarians was found solely for
the combined haplotypes of the three genes that included
LASS1 (CCT), showing an OR of 12.52. For male centenarians, it
was instead the LASS1 (CGT) haplotype with an OR of 12.40.
The results in the Georgia sample were replicated in the Louisiana population (Table 1). For female nonagenarians, the combined haplotypes that included LASS1 (CCT) were associated
with exceptional longevity with an OR of 3.12. For male nonagenarians this combination included LASS1 (CGT) and an OR of
4.86.

Gene combination associated with healthy aging
We next examined the question whether the genetic combination that contributes to exceptional longevity is also associated with ‘healthy aging.’ Healthy aging is a concept that is
difficult to define adequately. We elected to quantify healthy
aging using the frequency of self-reported deficits (Rockwood
& Mitnitski, 2007) in the Louisiana nonagenarians (Table S6).
For this purpose, we surveyed subjects for the presence of
42 medical conditions or functional limitations and summed
them for each nonagenarian. We then partitioned the subjects into tertiles based on the number of deficits reported;
tertile 1 had the fewest deficits, while tertile 3 had the
greatest number of deficits. A Kaplan–Meier survival analysis
was performed for each of the tertiles (Fig. 3). Examining the
entire sample of nonagenarians from Louisiana, the survival
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Fig. 3 Survival of nonagenarians as a function of their healthy aging profile. Kaplan–Meier survival of all nonagenarians in the Louisiana sample is plotted after
partitioning individuals into tertiles of deficit accumulation. Deficit count increases from tertile 1–3. Mortality was assessed on follow-up after enrollment.
Censoring is indicated by the symbols.

curves are significantly different (Wilcoxon v2ð2Þ = 20.06,
P < 0.0001).
We then searched for genetic associations with healthy aging
by examining the haplotypes in the three genes in the tertile
with the fewest deficits vs. that with the most (Table 1). The
results indicate that the combination of the same haplotypes in
the three genes is associated with healthy aging but only for the
combination including LASS1 (CGT). The OR for this association
was 15.48 for the European subpopulation in Louisiana.

Functional impact of gene variants
The marked difference in the effects of the two LASS1 haplotypes suggests that they could have functional consequences.
Variants in the APOE promoter at )491 and )219 are known to
affect the expression of this gene at the transcription level (Artiga et al., 1998a,b). The combination we have found in the haplotype associated with exceptional survival elicits a moderate
level of expression, approximately one-half of maximal. Because
LASS1 only has an effect when a combination of haplotypes in
APOE and HRAS1 is present, and this effect differs depending
on the particular LASS1 haplotype, we examined the variants in
the LASS1 gene for their potential role in transcription of the
gene, using a luciferase reporter assay. The results indicate that
compared to the AGC haplotype the CCT- and CGT-containing
promoters were 48% and 29% more active, respectively
(Fig. 4). Thus, the variation observed in our study appears to be
functional in determining mRNA expression levels. Perhaps, the
more moderate expression of LASS1 in males promotes healthier
aging. It is noteworthy that varying expression of the LASS1
homolog in yeast, LAG1, affects the observed life extension
(Jiang et al., 2004).

Fig. 4 Impact of polymorphisms in LASS1 on gene expression. A luciferase
reporter assay was used for determining the promoter activity in transfected
HeLa cells. Error bars denote SEM for six independent experiments with at
least six replicates for each of the four promoter constructs shown. The LASS1
promoter variants CCT and CGT associated with exceptional longevity were
compared to an AGC variant. The control is a reporter lacking inserted
promoter sequences.

Discussion
We have found a combination of variants in three genes that is
associated not only with exceptional longevity but also with
healthy aging. This is a novel finding. An association of HRAS1
with longevity was found before, and an interaction with the
mitochondrial genome was demonstrated (Bonafé et al., 2002).
A compensatory effect in late life of variants in one gene for the
deleterious effects of variants in a second gene has also been
described (Bergman et al., 2007). The combined effect
described here involves three genes and extends the association
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with exceptional survival to the functional outcome of health in
old age. Genetic interactions play an important role in complex
traits, but they can be difficult to find unless a hypothesis-driven
approach such as we use here is employed that reduces the scale
of the search and affects the prior probabilities involved (Thornton-Wells et al., 2004; Flint & Mackay, 2009). Unmasking the
interactions of common variants mitigates the necessity of
invoking the wide involvement of rare variants in complex traits.
The association with healthy aging and the profile of increasing frequencies of the haplotypes with age indicates that the
three genes studied here are not frailty genes or haplotypes but
instead genetic determinants of longevity. The foundation for
the genetic interaction is laid by the haplotype in APOE. HRAS1
has a synergistic effect, and this combined effect is further
enhanced by either of the two LASS1 haplotypes in a synergistic
manner. Our results point to the importance of accounting for
population heterogeneity in association studies (Dai et al.,
2007). The African-origin subpopulation displays a very low frequency of the crucial APOE haplotype, as well as a reduced frequency of the LASS1 haplotypes. Thus, intrinsic genetic
differences between the European and African subpopulations
can explain the lack of observation of the three-gene interaction
in the latter group. On the other hand, the associations we have
discovered in the European-origin sample from Georgia are replicated in the corresponding Louisiana sample, though the haplotype structures in the two samples differ. It will be important
to examine samples from additional populations for these associations to further generalize our findings and to explore potential nuances in the haplotypic effects.
There are two different haplotypes in LASS1 that play a role in
the three-gene combination described here. One appears to
operate in females and the other in males to determine exceptional longevity. Furthermore, it is only the latter that is associated with healthy aging. Thus, similar but distinct mechanisms
of aging are at play. Differences in genetic associations with
exceptional longevity between the genders have been noted
previously (De Benedictis et al., 2001). Interestingly, the cognition and physical function ability of male centenarians is often
greater than for their female counterparts, even though they are
outnumbered by them (Terry et al., 2008). Survival to exceptional old age, however, can occur due to delay or escape from
morbidity, as well as survival in its presence, regardless of gender
(Evert et al., 2003; Terry et al., 2008). The promoter analyses
suggest that an enhanced LASS1 activity is conducive to longevity. They further suggest that healthy aging in nonagenarians
depends on a somewhat lower enhancement of this promoter
activity. This could, for example, be related to moderation in
apoptosis-promoting activity coupled to sufficient enhancement
of cholesterol clearance by ceramide. Our results support a
model (Fig. 5) postulating that metabolic (lipid) stress induces
protective responses. However, at some point, removal of damaged cells is needed. Confirmation of this model will require the
longitudinal study of appropriate endophenotypes.
The haplotypes in the three genes are all present at high frequency in the European subpopulation in both Georgia and Lou-
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Fig. 5 Hypothetical model of the role of APOE, HRAS1, and LASS1
interactions. Circulating lipids are cleared by APOE and by HDL, which is aided
by LASS1-generated ceramide. Metabolic (lipid) stress induces protective
survival and stress responses, which are mediated ⁄ modulated by HRAS1 and
LASS1. Lipotoxicity enhances LASS1 production of ceramide, which signals
apoptosis removing damaged cells. These mechanisms become overwhelmed
with age resulting in dysfunction and morbidity.

isiana (Table 2). However, the congruence of the respective
haplotypes in all three genes is relatively infrequent in the population at large, although it increases in frequency dramatically
with age (Table 1 and Fig. 2). Thus, we have uncovered an
individual path to exceptional longevity and healthy aging, and
others remain to be found.

Experimental procedures
Study subjects
The Georgia sample (N = 650) was recruited in the Georgia
Centenarian Study from 44 counties in Northern Georgia. The
sampling frame consisted of voter’s registration files and lists
prepared from a survey of nursing homes and personal care
homes in the catchment area for centenarians and random digit
dialing for younger subjects. The Louisiana sample (N = 869)
was recruited in the Louisiana Healthy Aging Study from eight
parishes within a 40-mile radius of Baton Rouge. The sampling
frame consisted of the Center for Medicare and Medicaid Services enrollment database for subjects 65 and older and voter’s
registration files for younger individuals. Age of subjects was
verified using both demographic questionnaires and documentary evidence. Mortality data were collected using Social Security
Death Index search. Subjects provided informed consent according to protocols approved by the respective institutional review
boards. The demographic characteristics of the samples are
tabulated (Table S7).

Genotyping
Small subsets of samples from Georgia and Louisiana were first
independently genotyped to identify all detectable variation in
the selected genomic regions. Only polymorphisms present at
‡ 0.09 frequency were chosen for subsequent analysis in all
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samples. This provided sufficient power (> 0.95) to detect associations with exceptional longevity (Dai et al., 2007). Genomic
regions of interest were then amplified by the polymerase chain
reaction (PCR). The primers, forward and reverse respectively,
used to amplify the DNA regions of interest by the PCR were as
follows: (i) the promoter region of the APOE gene, 5¢GCGTCTGAGCGTTCACTGT-3¢ and 5¢-GTCCCAGTCTCGCATTCCT-3¢; (ii) exon 4 of APOE, 5¢-CTTGGGTCTCTCTGGCTCATC3¢ and 5¢-GCAGCCTGCACCTTCTCC-3¢; (iii) promoter of LASS1,
5¢-CAGCAAGTGACCCTCAGAGA-3¢ and 5¢-GACCTGGACCCCGAGAGA-3¢; (iv) exon1 of LASS1, 5¢-GCCTGGGTTTCTCTGCTG-3¢ and 5¢-GCCCGAGAGACCTTATCCTG-3¢; (v) promoter
of HRAS1, 5¢-ATCCCAGCCTTTCCCCAG-3¢ and 5¢-TTCGCCCCGCGCATGGGCT-3¢; (vi) exon 1 of HRAS1, 5¢-CAGGAGACCCTGTAGGAGGA-3¢ and 5¢-CCTATCCTGGCTGTGTCCTG-3¢.
Amplicons were verified by agarose gel electrophoresis, and
cleaned DNA was subjected to cycle-sequencing using the BigDye Terminator Reagent version 3.1 (Applied Biosystems, Foster
City, CA, USA) and the same primers, and the 3130xl DNA
sequencing system (Applied Biosystems). Identification of alleles
was aided by the SNP detection and base-calling software
SEQSCAPE v2.5 (Applied Biosystems). To minimize errors, both
strands of DNA were sequenced twice independently. The
genotyped loci included SNP: rs449647, rs769446, rs405509,
rs429358, rs7412, rs8176330, rs8176331, rs8176332,
rs8176333, rs8176334, rs8176335, rs12628, rs60774903,
rs3746263, and an SNP in exon 1 (+234) in LASS1 that is not
found in dbSNP. The genotyped loci are tabulated (Table S8).
Some of the Louisiana samples were genotyped using the
SNPlex technology (Applied Biosystems), which is based on the
oligonucleotide ligation assay combined with multiplex PCR
amplification. Primers were designed according to the SNPlex
Design Pipeline for the following SNP: rs449647, rs769446,
rs405509, rs8176330, and rs3746263. Size fractionation of
genotype-specific products was performed by capillary electrophoresis using the 3130xl DNA Analyzer, and genotype calls
were made using the GENEMAPPER v4.0 software (Applied Biosystems). The SNPlex genotyping was repeated twice independently.
The two polymorphisms in the coding region (rs429358 and
rs7412) account for the occurrence of three alleles, e2, e3, and
e4, which result in the three major isoforms, E2, E3, and E4 of
APOE, respectively. The E2, E3, and E4 isoforms differ on amino
acid sequence at site A (residue number 112) and site B (residue
number 158) in exon 4. For HRAS1 and LASS1 SNP, their locations are relative to the first nucleotide of the translation start
codon, whereas the transcription start site was used for the
APOE SNP.

Population stratification using Structure
Identification of ethnic origins of individuals using Alu insertion
polymorphisms was performed as described (Bamshad et al.,
2003; Watkins et al., 2003; Ray et al., 2005). DNA samples
were genotyped at 100 separate Alu loci located throughout

the genome. The Alu sequences were amplified by PCR using
locus-specific primers. The PCR fragments were separated by
agarose gel electrophoresis. The primers and methods used have
been described (Bamshad et al., 2003; Watkins et al., 2003; Ray
et al., 2005). Subjects were classified as one or the other of the
possible homozygotes based on the presence of a particular Alu
sequence at a given locus or as heterozygotes. The Alu genotypes thus obtained were analyzed to assign ethnic affiliation
using Structure (Pritchard et al., 2000). For this purpose, the
same Alu genotypes from 715 independent DNA samples from
subjects from around the world were used (Bamshad et al.,
2003; Watkins et al., 2003; Ray et al., 2005). These samples
spanned the geographic regions of Europe, Africa, Asia, and
India and included sampling of individuals from many populations in each region (31 total). Subjects were then assigned to
populations of origin corresponding to these geographic regions
using an assignment probability of 0.9.

Plot of pairwise linkage disequilibrium (LD)
comparison
Haplotype blocks for the three genes were examined using
Haploview. The standard color scheme is used for D¢ ⁄ LOD
values: bright red (D¢ = 1, LOD ‡ 2); blue (D¢ = 1, LOD < 2);
shades of pink ⁄ red (D¢ < 1, LOD ‡ 2); white (D¢ < 1, LOD < 2).
The numbers shown inside the boxes are D¢ values · 100
(empty boxes represent the D¢ value of 1). Haplotype blocks
are defined based on confidence bounds on D¢. If the onesided upper 95% confidence bound on D¢ lies between 0.7
and 0.98, the SNP pairs involved are considered to be in
strong LD (Gabriel et al., 2002). Haploview was also used to
examine the Hardy–Weinberg equilibrium. None of the 15
SNP examined in this study showed significance for departure
from Hardy–Weinberg proportions in the Georgia and Louisiana samples stratified by Structure at 0.9 assignment probability. Haploview is available at: http://www.broad.mit.edu/
mpg/haploview.

Promoter analysis of LASS1 haplotypes
A 1755-bp DNA fragment containing the putative promoter
region and part of the coding region of LASS1 was PCR-amplified from appropriate genomic DNA samples using EcoRV and
BglII-tagged primers and cloned into the Pgl4.10 vector (Promega, Sunnyvale, CA, USA). The cloned sequence is in frame
with the firefly luciferase coding sequence in the vector. Then,
an additional 1040-bp fragment tagged with XhoI and EcoRV
was added upstream of the original clone. The translational start
codon of LASS1 was changed to TAG by site-directed mutagenesis. The correctness of the final constructs was verified by
sequencing. The only sequence differences between the constructs were at the polymorphic sites of interest specified below.
Transfection of HeLa cells was performed using the PolyFect
transfection reagent (Qiagen, Valencia, CA, USA) per the protocol provided. Co-transfection was carried out with mixtures
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of one of the experimental constructs (0.4 lg) with a control
vector, Pgl4.73 (10 ng), which carries a Renilla luciferase coding sequence under the SV40 promoter. The experimental constructs were either Pgl4.10 without LASS1 promoter
sequences or Pgl4.10 with one of three different LASS1
sequences. These had the following bases at positions )718,
+216, and +234, respectively: AGC, CCT, or CGT. Following
24-h incubation, luciferase activities were measured using the
Dual-Glo Luciferase Assay (Promega) per the protocol
provided, using a Modulus Microplate Luminometer (Turner
BioSystems, Sunnyvale, CA, USA). The firefly luminescence
readings were normalized to the Renilla luminescence
readings. There were at least six replicates of each assay per
experiment.

Deficit index
Following previously published reports (Kulminski et al., 2008;
Searle et al., 2008), our deficit index was derived as the
un-weighted count of the number of deficits divided by the total
number of possible deficits for an individual. The self-reported
medical history questionnaire was administered to all study participants, and its components were used to construct the deficit
index. This was supplemented with items from an activities
of daily living (ADL) questionnaire. Responses were grouped to
create broader categories where similar ailments were defined
more than once. After applying the above criteria, 42 deficits
were included in the compilation of the index.

Statistical analysis
There is substantial evidence supporting the hypothesis of association with exceptional longevity of variants in the three candidate genes chosen here for analysis. This information is
presented in this paper. APOE has been replicated as a longevity-determining gene in numerous studies (Christensen et al.,
2006). This gene anchors the interaction described in this report
(Fig. 5). The hypothesis we test is related to the role of the apolipoprotein APOE in lipid and lipoprotein metabolism. The BioSystems Database (NCBI) lists 228 genes under the entry
‘Metabolism of Lipids and Lipoproteins.’ APOE and LASS1 are
among them. Thus, we assume the prior probability of an interaction of these genes to be  1.0. It is likely that there are genes
involved in lipid and lipoprotein metabolism in addition to the
228, and we conservatively propose there to be 300. We therefore assume the prior probability of identifying another interacting gene, such as HRAS1, to be  300 ⁄ 30 000 or  0.01. We
set the posterior probability for identification of such a gene at
0.95. Applying Bayes’ theorem, we obtain the likelihood ratio
Pr(Data|Association) ⁄ Pr(Data|NoAssociation) of 1881. These
considerations are applicable to the initial test of the association
with longevity of the combination of the haplotypes in the three
genes in both the Georgia and Louisiana populations. The prior
probability increases dramatically in subsequent tests, once the
initial association is identified.

APOE allele frequencies and genotype frequencies were compared between centenarians ⁄ nonagenarians and young controls with a 2 · 3 contingency table (for alleles) or with a 2 · 6
contingency table (for genotypes). The contingency tables were
evaluated by Fisher’s exact probability test (Sanchez et al.,
2006), using SAS v9.13 software (SAS Institute Inc., Cary, NC,
USA). A P-value < 0.05 was considered statistically significant.
All statistical tests of significance reported in this study are
two-sided.
Structure v2.2 (Pritchard et al., 2000) was used to infer population structure for the 650 Georgia subjects and the 869 Louisiana subjects, respectively. Seven hundred and fifteen subjects of
known geographic ancestry (European, African, Asian, or
Indian) were used as reference. For each individual, Structure
2.2 estimates the proportion of ancestry from each of four populations. We used a burn-in of 15 000 iterations and a run of
20 000 replications. Three replicate runs were performed on
each dataset. The largest proportion values in each run were
used to calculate the average ancestry proportion for each individual. Individuals were either assigned to a specific geographic
origin if the average was larger than a predetermined assignment probability (0.9 in this study) or considered admixed if the
average was less. All haplotype analyses were performed on
samples stratified for ethnic affiliation, as described here.
Linkage disequilibrium approaches to the analysis of gene–
gene interactions have been proposed (Zhao et al., 2006), and
the modeling of gene–gene interactions using association analysis of noncontiguous haplotypes has been implemented (Woo
et al., 2006). We took a similar approach. The haplotype frequencies for the combination of SNP in APOE, HRAS1, and
LASS1 were estimated by an Expectation-Maximization (EM)
algorithm implemented in Arlequin (Excoffier et al., 2005). The
SD was determined by the parametric bootstrap procedure in
Arlequin (100 bootstraps). Those haplotype combinations present at a frequency of  0.01 or greater in the 20- to59 -year-old
group in Georgia and in Louisiana were analyzed further. This
cutoff was taken based on the considerations from comparison
of statistical and molecular haplotyping for sample sizes as small
as 17 (Tishkoff et al., 2000). The frequency estimates in case
and control groups were used to generate 2 · 2 contingency
tables to test significance of associations of the respective haplotype combinations with exceptional longevity. Fisher’s exact test
was used to assess significance. The sequential Dunn-Sidak procedure was used to adjust the exact P-values for multiple comparisons of haplotype combinations. The adjustment included
seven such combinations independently identified in the Georgia and Louisiana samples in the subpopulations of European
origin (Table S4). In the African-origin subpopulations, there
were seven and three such combinations in these samples,
respectively. A stringent criterion of adjusted P < 0.01 (twosided) was used to identify the potentially interacting combination of haplotypes in the three genes.
The two significant haplotype combinations found to be associated with exceptional longevity in the independent analyses in
the Georgia and Louisiana samples were then evaluated in men
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and women in these two samples, as well as for the tertiles of
deficit accumulation in the Louisiana population. The same
 0.01 frequency cutoff was applied. This involved adjustment
for up to two comparisons, using the sequential Dunn-Sidak
procedure. The haplotype combination frequencies differed significantly in the various samples examined. These haplotype
combinations are common in the relevant samples characterized
by longevity and ⁄ or healthy aging. The three-gene haplotype
combinations reported here are associated with certain
additional healthy-aging phenotypes but not with others (in
preparation).
The APOE and APOEÆHRAS1 haplotypes derived from the
significant haplotype combinations in the three genes were
also evaluated independently for association with exceptional
longevity, using the above procedures.
Nonagenarians were classified by tertile according to their
deficit accumulation, as described above. The Kaplan–Meier
survival was plotted for each tertile. The differences between
tertiles were evaluated by the Wilcoxon test (a two-sided
P < 0.05 was considered significant). SAS v9.13 software was
used for Kaplan–Meier survival analysis.
The significance of differences in promoter strength determined using the luciferase reporter assay was evaluated for
six independent experiments in which the control (no LASS1
promoter sequences) and the three LASS1 promoter haplotypes were compared. One-way ANOVA was used to first test
for any differences, using a criterion of P < 0.05 (two-sided).
Then, all pairwise combinations were evaluated in a twotailed Newman–Keuls test, implemented in STATMOST
(DataMost Corp., Sandy, UT, USA). A P-value of < 0.05 was
considered significant.

Acknowledgments
Supported by grants from the National Institute on Aging of the
National Institutes of Health (P01 AG017553 and P01
AG022064) and by the Louisiana Board of Regents through the
Millennium Trust Health Excellence Fund [HEF(2001-06)-02]. We
thank the people of Georgia and Louisiana for participation in
our study. We acknowledge the valuable recruitment, data
acquisition, data management, and fiscal management efforts
of M. Burgess, K. Grier, E. Jackson, E. McCarthy, K. Shaw, L.
Strong, S. Reynolds, S. Anderson, E. Cassidy, M. Janke, T. Savla,
M. Durden, M. Cervantes, D. Rouzan, and T. Beard.
Additional authors include for The Georgia Centenarian
Study: R.C. Green, M. Gearing, W.R. Markesbery, J.L. Woodard,
M.A. Johnson, J.S. Tenover, I.C. Siegler, P. Martin, M. MacDonald, C. Rott, W.L. Rodgers, and A. Davey; for The Louisiana
Healthy Aging Study: M. Allen, I.E. Antikainen, A.M. Arce, J.
Arceneaux, E.O. Boudreaux, L. Byerley, P.A. Callinan, C.M.
Champagne, H. Cheng, Y.-w. Chiu, L. Cosenza, M.E. Cress, M.
Czarny-Ratajczak, J.P. DeLany, J. Denver, A. Deutsch, M.J.
deVeer, D.A. Dobrosielski, R. Ellis, A. Ermolao, M. Erwin, M.
Erwin, J. Fabre, E. Fontham, M. Frisard, P. Geiselman, L. Goodwin, V. Greco, S. Hadie, T. Hall, M. Hamilton, S.W. Herke, K.

Hawley, J. Hayden, K. Hebert, F. Holton, H.-C. Hsu, D. Johannsen, L. Kawasaki, B. Kimball, C. King-Rowley, M. Konkel, R.
Kuhn, K. Landry, C. Lavie, D. LaVie, M. Leblanc, H.-Y. Lin,
K. Lopez, B. McEvoy-Hein, J.D. Mountz, E. Olinde, J. Owens,
K. Pedersen, A. Pellett, P. Remedios, Y. Robertson, J. Rood, H.
Rothschild, R.A. Russell, E. Sandifer, B. Schmidt, R. Schwartz,
D.K. Scott, J. Silva, F.N. Standberry, J. Thomson, A. Tiwari, V.
Toups, C. Traylor, C. Velasco-Gonzalez, C. Waguespack, X.-Y.
Wang, R.H. Wood, Q. Yu, S. Zehr, and P. Zhang.

Author contributions
S.M.J., L.W.P., M.A.B., D.A.W., L.J.S., D.B.H., E.R., K.E.C., and
M.A.W. designed the research; S.K., L.L., X.B., J.C.J., J.A.W.,
C.M.L., J.V., L.M., L.J.S., D.B.H., M.V.M., and K.E.C. acquired
data; J.A. and J.D. contributed new analytic tools; S.M.J., S.K.,
J.D., X.B., J.A., M.A.B., D.A.W., C.M.L., J.V., L.M., and L.J.S.
analyzed and interpreted data; and S.M.J., S.K., and J.D.
prepared the manuscript.

References
Artiga MJ, Bullido MJ, Sastre I, Recuero M, Garcia MA, Aldudo J, Vázquez J, Valdivieso F (1998a) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421,
105–108.
Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, Garcia MA,
Lendon CL, Han SW, Morris JC, Vázquez J, Goate A, Valdivieso F
(1998b) Risk of Alzheimer’s disease correlates with transcriptional
activity of the APOE gene. Hum. Mol. Genet. 7, 1887–1892.
Bamshad MJ, Wooding S, Watkins WS, Ostler CT, Batzer MA, Jorde
LB (2003) Human population genetic structure and inference of
group membership. Am. J. Hum. Genet. 72, 578–589.
Bergman A, Atzmon G, Ye K, MacCarthy T, Barzilai N (2007) Buffering mechanisms in aging: a systems approach toward uncovering
the genetic component of aging. PLoS Comput. Biol. 3, e170.
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Table S3 Lack of association with exceptional longevity of variants in HRAS1 and LASS1 in the major population strata
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